Winmill & Co’s Nutex Health NUTX Stock Holding History

Winmill & Co’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.2M	Hold	65,350	–	–	2.47%	17
2026 Q1	$6.21M	Buy	+65,350	New	+$8.01M	1.79%	18

Other funds holding NUTX

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Winmill & Co's NUTX Position: Q2 2026 in Review

Winmill & Co held its Nutex Health (NUTX) position steady in Q2 2026 at 65,350 shares worth $11.2M. The position accounts for 2.47% of the portfolio, ranked #17.

Winmill & Co first reported a position in NUTX in Q1 2026 and has held it in 2 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

Winmill & Co held 65,350 shares of Nutex Health worth $11.2M as of Q2 2026.
Winmill & Co left its Nutex Health share count unchanged in Q2 2026.
Nutex Health made up 2.47% of Winmill & Co's portfolio in Q2 2026, its #17 holding.
Winmill & Co first reported a position in Nutex Health in Q1 2026 and has held it in 2 quarters since.
154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Winmill & Co's 13F filing for Q2 2026, filed 13 Aug 2026.